ArticleDiagnostics (Basel, Switzerland)2026
Romosozumab Versus Teriparatide for Fracture Prevention, Cardiovascular Events, and Mortality in Osteoporosis: A Propensity Score-Matched Real-World Cohort Study.
Jer-Yung Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.